EZH2 and breast cancer: Further analysis revealed that VEGFA and EZH2 were negatively correlated with their respective upstream miRNAs in breast cancer and were significantly overexpressed in breast cancer compared with normal breast controls and indicated poor prognosis of patients with breast cancer.